Opioid Use Disorder study: HC-MOUD Only
Official title Integrating MOUD in Nonmedical Community Settings (Better Together)
ClinicalTrials.gov ID: NCT06416020
What this study is testing
- What it's testing
- This study wants to find out if a new way of providing opioid treatment in community settings helps people stay in treatment for 24 weeks compared to standard clinic-only care.
- Who it's for
- People living in urban areas with high overdose rates who are receiving treatment for opioid use disorder.
- What's involved
- Participants will receive buprenorphine (a medication for opioid use) via video call from a main clinic and get coaching support in person at a local community organization.
- Time commitment
- The study lasts 24 weeks and involves regular check-ins and visits to the community site.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 and older
You may be able to join if
- Be 16 years of age or older
- Has been newly prescribed MOUD with buprenorphine by a hub clinic provider no more than 90 days before the day of randomization or on the day of...
- Is willing and able to provide written informed consent
- Is willing and able to provide reliable locator information to facilitate contacting the participant for research follow-up assessments
- Speaks English well enough to be able to comprehend the study procedures and complete the assessments
You likely can't join if
- In the 30 days prior to receiving the prescription for MOUD with buprenorphine from the hub clinic provider, has been covered by MOUD (oral...
- Plans to move out of the area or anticipate not being able to remain in the study for 6 months
- Is currently in jail, prison, or other overnight facility as required by a court of law or have pending legal action that could prevent participation...
- Has been previously enrolled in CTN-0144 or CTN-0088 or is currently enrolled in another clinical trial for treatment of OUD
The study team makes the final eligibility decision.
Where it is enrolling
- Washington D.C., District of Columbia, United States
- Miami, Florida, United States
- Chicago, Illinois, United States
- Baltimore, Maryland, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Washington D.C., District of Columbia, United States; Miami, Florida, United States; Chicago, Illinois, United States; Baltimore, Maryland, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.